Can at-home genetic tests improve rare diagnosis?

The explosion of the direct-to-consumer DNA testing market could be transformative if genomics data is used in conjunction with the NHS to improve our understanding of rare diseases

Ultra-rare disease diagnosis is an uphill battle

Incredibly uncommon and hard to diagnose and treat, how can we advance the treatment of ultra-rare diseases if there are still so many unknowns?

How better genetic screening could save babies’ lives

Babies are tested for a number of conditions soon after birth, but varied approaches to screening worldwide highlight how fragmented the medical profession remains over this vital process

It’s time to make rare diseases a priority

‘If we embrace our genomic future, we stand to transform the prospects for diagnosis and treatment of rare and common diseases alike’

The true cost of white-washed research

Genetics and medical studies have largely over-represented people of white, European descent, which could have huge ramifications for the advancement of health research

Pill journey along complex supply chains

New technologies, such as the cloud and artificial intelligence, have transformed pharmaceutical supply chains from materials supplier to manufacturer, wholesaler to pharmacy and on to patients

EU ruling on gene-edited foods is holding us back

Gene-edited food has the potential to feed the world’s hungry, but may be blocked in the European Union

Why genome sequencing is the future of healthcare

Healthcare companies are developing technology which utilises the power of artificial intelligence to analyse genomic data and provide personalised treatment for cancer patients